Trilobio
Developer of an end-to-end automated synthetic biology platform designed to provide medical services. The company's platform specializes in assembling deoxyribonucleic acid as a service with end-to-en...
Valuation
$25M
Market implied
Share Price
N/A
Total Raised
$11M
Last Round
N/A